To protect the QuickVue kit against moisture and other environmental conditions, the company integrated Aptar CSP Technologies’ Activ-Film technology.
The QuickVue® SARS Antigen test is a point-of-care rapid antigen test developed by Quidel® Corporation, a leading manufacturer of diagnostic healthcare solutions, that delivers test results in 10 minutes. The new rapid diagnostic received Emergency Use Authorization (EUA) from the U.S. FDA in late Dec. 2020.
The visually read test requires no supplemental instrumentation and offers expanded access to affordable and accurate COVID-19 testing that will help meet the urgent testing needs of the global economy, including for those in school systems and rural areas.
Companies in this article
